BM

Bhumikaben Mohanbhai Desai

Active Director Director DIN 11545322
DIN 11545322 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhumikaben Mohanbhai Desai

Data last updated:

Bhumikaben Mohanbhai Desai is a Director at Aetreon Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11545322
Primary Designation Director
Industry Pharma
First Appointment 13 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Feb 20262026Active

Board colleagues of Bhumikaben Mohanbhai Desai

NameDINCompanyDesignation
Jatin Thakorbhai Vashi11545321Aetreon Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aetreon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Bhumikaben Mohanbhai Desai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhumikaben Mohanbhai Desai

Bhumikaben Mohanbhai Desai currently holds 1 directorship: Aetreon Pharmaceuticals Private Limited (Director, since 13 Feb 2026).

Bhumikaben Mohanbhai Desai was first appointed on 13 Feb 2026 as Director at Aetreon Pharmaceuticals Private Limited.

The current boards of Bhumikaben Mohanbhai Desai's companies include Jatin Thakorbhai Vashi (Aetreon Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available